Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- "Wockhardt submits new drug Application to U.S. FDA for Zidebactam-Cefepime (WCK 5222) for Treatment of serious Gram-Negative Infections".
01-Oct-2025
Download PDF
Wockhardt
Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- "Wockhardt submits new drug Application to U.S. FDA for Zidebactam-Cefepime (WCK 5222) for Treatment of serious Gram-Negative Infections".
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds